COVID-19 trials registries data warehouse

http://www.chictr.org.cn/showproj.aspx?proj=49510

Zhaohui Tong

13910930309@163.com

2020-02-20

Recruiting

RCT

Randomized

Parallel

Open label

single-center

Treatment

1. Voluntarily sign the Consent Form, 2. Male or female aged 18 and over, 3. According to the Diagnosis and Treatment Scheme for Pneumonia of Novel coronavirus pneumonia Infection-Trial Fifth Edition , inpatient diagnosed with Novel coronavirus pneumonia diagnosed and clinical classification of ordinary type: Inpatients with fever (underarm temperature >= 37.0 degree C), respiratory tract, etc. Imaging shows pneumonia.

1. Females who are pregnant or likely to be pregnant, or who are lactating and unable to stop breastfeeding, or who have positive pregnancy tests during screening, 2. Males or females who have a birth plan or are unwilling to take reliable contraceptive measures for contraception within 90 days from signing the informed consent to the last dose, 3. Other circumstances that the researchers consider inappropriate for participation in this study.

3

Beijing Chaoyang Hospital; Capital Medical University

18

None

China

Moderate disease at enrollment

3: Moderate disease at enrollment

60

Time to Clinical Recovery;

| Declared number of arm (3.0) differs from found arms (4.0)

Phase 2

[{"arm_notes": "", "treatment_id": 504, "treatment_name": "Favipiravir", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 504, "treatment_name": "Favipiravir", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 504, "treatment_name": "Favipiravir", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}]